Cargando…
AdipoRon exerts opposing effects on insulin sensitivity via fibroblast growth factor 21–mediated time-dependent mechanisms
Increasing evidence has shown that AdipoRon, a synthetic adiponectin receptor agonist, is involved in the regulation of whole-body insulin sensitivity and energy homeostasis. However, the mechanisms underlying these alterations remain unclear. Here, using hyperinsulinemic–euglycemic clamp and isotop...
Autores principales: | Wang, Yongliang, Liu, Huan, Zhang, Ruixin, Xiang, Yuyao, Lu, Junfeng, Xia, Bo, Peng, Liang, Wu, Jiangwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861110/ https://www.ncbi.nlm.nih.gov/pubmed/35090894 http://dx.doi.org/10.1016/j.jbc.2022.101641 |
Ejemplares similares
-
AdipoRon may be benefit for atherosclerosis prevention
por: Esfahani, Maryam, et al.
Publicado: (2017) -
AdipoRon, a new therapeutic prospect for Duchenne muscular dystrophy
por: Abou‐Samra, Michel, et al.
Publicado: (2020) -
AdipoRon Engages Microglia to Antinociception through the AdipoR1/AMPK Pathway in SNI Mice
por: Fang, Qian, et al.
Publicado: (2023) -
AdipoRon and Other Adiponectin Receptor Agonists as Potential Candidates in Cancer Treatments
por: Nigro, Ersilia, et al.
Publicado: (2021) -
Adiponectin receptor agonist AdipoRon relieves endotoxin-induced acute hepatitis in mice
por: Xiao, Wen-Ze, et al.
Publicado: (2019)